Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

NCT03219320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathy

Interventions

DRUG: NYX-2925
DRUG: Placebo

Sponsor

Aptinyx

Collaborators

[object Object]